Cell

Beta-catenin

Biology

Cancer

Wnt signaling pathway

Chemistry

Immunology

Immunosuppression

Catenin

Cell growth

Signal transduction

Cell biology

Cancer research

Genetics

Cancer cell

Nature Cell Biology

Many cancers have an unusual dependence on glutamine. However, most previous studies have focused on the contribution of glutamine to metabolic building blocks and the energy supply. Here, we report that cancer cells with aberrant expression of glutamate decarboxylase 1 (GAD1) rewire glutamine metabolism for the synthesis of γ-aminobutyric acid (GABA)—a prominent neurotransmitter—in non-nervous tissues. An analysis of clinical samples reveals that increased GABA levels predict poor prognosis. Mechanistically, we identify a cancer-intrinsic pathway through which GABA activates the GABAB receptor to inhibit GSK-3β activity, leading to enhanced β-catenin signalling. This GABA-mediated β-catenin activation both stimulates tumour cell proliferation and suppresses CD8+ T cell intratumoural infiltration, such that targeting GAD1 or GABABR in mouse models overcomes resistance to anti-PD-1 immune checkpoint blockade therapy. Our findings uncover a signalling role for tumour-derived GABA beyond its classic function as a neurotransmitter that can be targeted pharmacologically to reverse immunosuppression. Huang et al. report upregulation of GABA synthesis and activation of β-catenin after rewiring of glutamine metabolism, which suppresses T-cell infiltration, enhances tumour growth and can be targeted to overcome resistance to immune checkpoint blockade.

Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression